Our results revealed that the VNS-induced enhancement of USP10 was a mechanism to attenuate neurological dysfunction, neuroinflammation, and glial cell activation caused by ischaemic stroke, and this effect was achieved by the modulation of the NF-κB signaling pathway. The gene discussed is USP10; the disease is ischemic stroke.